Disease
3 developments in the corpus
Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
Latest
Everything in the corpus, newest first.
AUG 13, 2026 · OBSERVATIONAL STUDY
ClinicalTrials.gov
This is a registry record for an ongoing observational cell-harvesting study with no reported results; it describes planned enrollment and procedural outcomes only, not clinical efficacy or safety data.
AUG 11, 2026 · PHASE 1 TRIAL
ClinicalTrials.gov
Phase 1 dose-escalation study of a novel biologic in early-stage development; no results are posted in this registry record, only planned study design and safety endpoints.
AUG 10, 2026 · PHASE 1/2 TRIAL
ClinicalTrials.gov
This is an active clinical trial registry record with no reported results; Phase 1/2 design studying an investigational drug in a molecularly defined population with safety and dose-finding as primary objectives.